Johnson  Johnson Consumer Health Unit Kenvue Prices IPO at $22 Per Share, Marking Largest U.S. IPO Since 2021
Trendline

Johnson Johnson Consumer Health Unit Kenvue Prices IPO at $22 Per Share, Marking Largest U.S. IPO Since 2021

What's Happening? Johnson & Johnson's consumer healthcare unit, Kenvue, has priced its initial public offering (IPO) at $22 per share, reaching the top end of its marketed range of $20.00 to $23.00. This IPO is set to raise approximately $2.8 billion, valuing Kenvue at about $41 billion, making it t
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.